Age Ayurveda Nighantu Ayurvedic practitioner? List or verify your practice

Yashtimadhu

Glycyrrhiza glabra

Yashtimadhu (Glycyrrhiza glabra) is a plant drug, from the Fabaceae family. WHO Monograph on Radix Glycyrrhizae published in WHO Monographs on Selected Medicinal Plants (Volume 1, 1999). NF-kB pathway inhibition: Glycyrrhizin blocks HMGB1-TLR4-NF-kB signaling, reducing pro-inflammatory cytokines (IL-6, TNF-alpha) in macrophages.

Key facts
Botanical nameGlycyrrhiza glabra
FamilyFabaceae · other entries in this family
OrderFabales
Pharmacopoeia statusWHO Monograph on Radix Glycyrrhizae published in WHO Monographs on Selected Medicinal Plants (Volume 1, 1999). European Medicines Agency (EMA) issued a Community Herbal Monograph for Glycyrrhiza glabra/inflata/uralensis radix with well-established and traditional use designations. Listed in European Pharmacopoeia (minimum 4% glycyrrhizic acid), British Pharmacopoeia, and Ayurvedic Pharmacopoeia of India. ESCOP monograph available. NCCIH (US NIH) maintains an active safety information page.
Taxon identifiersGBIF 2965732 · Wikidata Q52502809 · NCBI Taxonomy 49827

The evidence at a glance

12papers on this site for this drug, published 2017 to 2026, every one with a DOI.

  • 2Systematic reviews and meta-analyses
  • 1Randomised controlled trials
  • 9Other clinical studies and reviews

A count is not a conclusion and a tier is a study design, not a verdict. Each paper is listed with what it measured on the page below. See the research index for how papers are tiered.

Names and identification

LanguageName
EnglishLicorice (Liquorice)
SanskritYashtimadhu

How does it work?

  • NF-kB pathway inhibition: Glycyrrhizin blocks HMGB1-TLR4-NF-kB signaling, reducing pro-inflammatory cytokines (IL-6, TNF-alpha) in macrophages.
  • NLRP3 inflammasome: Inhibits NLRP3 inflammasome initiation and activation, attenuating IL-18, IL-1beta, TNF-alpha, IL-6, and PGE2 levels.
  • MAPK pathway: Attenuates activation of JNK, p38, and ERK mitogen-activated protein kinases.
  • Multi-pathway anti-inflammatory: Modulates NF-kB, MAPK, COX/LOX, and JAK/STAT pathways simultaneously.
  • Neuroprotection: Restores mTORC1-AMPK1 axis in autophagic regulation, preventing mitochondrial oxidative stress and apoptosis in Parkinson’s models.
  • Anti-ulcer: Prevents adhesion of Helicobacter pylori to gastric mucosa. Network of 29 phytochemicals acting on 157 target genes.
  • Antiviral: Glycyrrhizin inhibits viral replication and entry through multiple mechanisms including interference with viral surface glycoproteins.
  • Immunomodulatory: Modulates both innate and adaptive immune responses via regulation of cytokine networks.
  • Pseudoaldosteronism mechanism: Glycyrrhizic acid inhibits 11-beta-hydroxysteroid dehydrogenase type 2, preventing cortisol-to-cortisone conversion, leading to mineralocorticoid excess.
  • Key active constituents: Glycyrrhizin (glycyrrhizic acid, ~10% dry weight), glabridin, liquiritigenin, isoliquiritigenin, licochalcone A, and 18-beta-glycyrrhetinic acid.

What do recent studies show?

Only studies that could be traced to a published paper are listed here. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

  • CRITICAL: Chronic use or large doses (>30g/day for several weeks) of licorice can cause pseudoaldosteronism syndrome: hypertension, hypokalemia, sodium/water retention, suppressed renin and aldosterone.
  • Glycyrrhizin threshold for mineralocorticoid side effects: 0.7-1.4g glycyrrhizin (equivalent to 10-14g crude herb) in normal subjects.
  • Contraindicated in congestive heart failure, hypertension, renal disease, and hypokalemia.
  • Drug interaction: Potassium depletion increases risk of cardiotoxicity with cardiac glycosides (digitalis).
  • Drug interaction: May potentiate effects of corticosteroids and mineralocorticoids.
  • Drug interaction: May reduce efficacy of antihypertensive medications by causing sodium/water retention.
  • Drug interaction: May interact with diuretics, increasing risk of hypokalemia.
  • Drug interaction: May interact with anticoagulants (warfarin) — altered drug metabolism reported.
  • NCCIH (US NIH) warns that licorice root supplements can cause serious side effects when consumed in large amounts or for extended periods.
  • Deglycyrrhizinated licorice (DGL) formulations have a significantly improved safety profile for GI applications.
  • Avoid during pregnancy due to potential effects on cortisol metabolism and premature birth risk.

What is it made of?

The marker compounds are listed under Dosage forms and preparation, below.

Dosage forms and preparation

Dosage Forms: Churna (powder), Kwatha (decoction), Capsule, Tablet, Avaleha, Taila (medicated oil), Ghrita (medicated ghee), Lozenge/pastille, Syrup, DGL (deglycyrrhizinated licorice) chewable tablet

Standard Dosage: 1-3 g powder twice daily; 50-100 mL decoction; 250-500 mg standardized extract capsule twice daily; DGL: 380-760 mg chewed before meals; NOT to exceed 6 weeks continuous use at full dose

Optimal Timing: After meals for GI protection; before meals for appetite and digestive stimulation; with honey for respiratory conditions; limit to 4-6 weeks continuous use, then 2-week break

Storage: Airtight containers at 15-25 deg C. Root sticks very stable if kept dry. Powder protected from moisture (moderately hygroscopic). DGL products in standard pharmaceutical packaging.

Marker Compounds: Glycyrrhizin (glycyrrhizic acid), 18-beta-Glycyrrhetinic acid, Liquiritigenin, Isoliquiritigenin, Glabridin, Glabrol, Liquiritin, Formononetin, Hispaglabridin A

Synergistic Combinations

  • Vasa (Adhatoda vasica) - respiratory combination (expectorant + demulcent)
  • Amalaki - GI mucosal protection synergy
  • Ashwagandha - adaptogenic stress-relief combination
  • Tulsi - respiratory immune support
  • Pippali - bioenhancer for Yashtimadhu flavonoids
  • Milk as vehicle - cooling and Pitta-pacifying combination

Published research

Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.

Systematic reviews and meta-analyses2

  1. Prajapati K, Mishra R, Jain V. 2026. A comprehensive review of Glycyrrhiza glabra in the management of rheumatoid arthritis: ethnopharmacology, pharmacological mechanisms and synergistic therapeutic strategiesJournal of ethnopharmacology. PMID 41177239 · doi:10.1016/j.jep.2025.120827
  2. Dorsareh F, Vahid-Dastjerdi G, Bouyahya A and others. 2023. Topical Licorice for Aphthous: A Systematic Review of Clinical TrialsIranian journal of medical sciences. PMID 37786470 · doi:10.30476/IJMS.2022.94467.2576

Randomised controlled trials1

  1. Arentz S, Smith CA, Abbott J and others. 2017. Combined Lifestyle and Herbal Medicine in Overweight Women with Polycystic Ovary Syndrome (PCOS): A Randomized Controlled TrialPhytotherapy research : PTR. PMID 28685911 · doi:10.1002/ptr.5858

Other clinical studies and reviews9

  1. Wahab S, Ahmad I, Irfan S and others. 2022. Pharmacological Efficacy and Safety of Glycyrrhiza glabra in the Treatment of Respiratory Tract InfectionsMini reviews in medicinal chemistry. PMID 34579633 · doi:10.2174/1389557521666210927153001
  2. Bisht D, Rashid M, Arya RKK and others. 2022. Revisiting liquorice (Glycyrrhiza glabra L.) as anti-inflammatory, antivirals and immunomodulators: Potential pharmacological applications with mechanistic insightPhytomedicine plus : international journal of phytotherapy and phytopharmacology. PMID 35403088 · doi:10.1016/j.phyplu.2021.100206
  3. Markina YV, Kirichenko TV, Markin AM and others. 2022. Atheroprotective Effects of Glycyrrhiza glabra LMolecules (Basel, Switzerland). PMID 35897875 · doi:10.3390/molecules27154697
  4. Wahab S, Annadurai S, Abullais SS and others. 2021. Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and ToxicologyPlants (Basel, Switzerland). PMID 34961221 · doi:10.3390/plants10122751
  5. Rani K, Devi N, Saharan V and others. 2021. Glycyrrhiza glabra: An Insight to NanomedicineJournal of nanoscience and nanotechnology. PMID 34739794 · doi:10.1166/jnn.2021.19007
  6. Jafari F, Jafari M, Moghadam AT and others. 2021. A Review of Glycyrrhiza glabra (Licorice) Effects on Metabolic SyndromeAdvances in experimental medicine and biology. PMID 34981491 · doi:10.1007/978-3-030-73234-9_25
  7. El-Saber Batiha G, Magdy Beshbishy A, El-Mleeh A and others. 2020. Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae)Biomolecules. PMID 32106571 · doi:10.3390/biom10030352
  8. Kwon YJ, Son DH, Chung TH and others. 2020. A Review of the Pharmacological Efficacy and Safety of Licorice Root from Corroborative Clinical Trial FindingsJournal of medicinal food. PMID 31874059 · doi:10.1089/jmf.2019.4459
  9. Dhariwala MY, Ravikumar P. 2019. An overview of herbal alternatives in androgenetic alopeciaJournal of cosmetic dermatology. PMID 30980598 · doi:10.1111/jocd.12930

Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.